Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Ingevity (NGVT) EBIT (2016 - 2025)

Historic EBIT for Ingevity (NGVT) over the last 11 years, with Q3 2025 value amounting to $81.8 million.

  • Ingevity's EBIT fell 285.04% to $81.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.7 million, marking a year-over-year increase of 20542.17%. This contributed to the annual value of $73.7 million for FY2024, which is 1450.12% down from last year.
  • Latest data reveals that Ingevity reported EBIT of $81.8 million as of Q3 2025, which was down 285.04% from $64.0 million recorded in Q2 2025.
  • In the past 5 years, Ingevity's EBIT ranged from a high of $111.2 million in Q3 2022 and a low of -$145.4 million during Q4 2024
  • Over the past 5 years, Ingevity's median EBIT value was $67.4 million (recorded in 2023), while the average stood at $46.5 million.
  • Its EBIT has fluctuated over the past 5 years, first plummeted by 38618.93% in 2023, then skyrocketed by 39415.2% in 2025.
  • Quarter analysis of 5 years shows Ingevity's EBIT stood at $45.8 million in 2021, then dropped by 14.63% to $39.1 million in 2022, then plummeted by 386.19% to -$111.9 million in 2023, then decreased by 29.94% to -$145.4 million in 2024, then skyrocketed by 156.26% to $81.8 million in 2025.
  • Its EBIT stands at $81.8 million for Q3 2025, versus $64.0 million for Q2 2025 and $50.3 million for Q1 2025.